Page last updated: 2024-10-21

4-aminopyridine and Ataxia of Gait

4-aminopyridine has been researched along with Ataxia of Gait in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schniepp, R1
Wuehr, M1
Neuhaeusser, M1
Benecke, AK1
Adrion, C1
Brandt, T1
Strupp, M1
Jahn, K1
Löhle, M1
Schrempf, W1
Wolz, M1
Reichmann, H1
Storch, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase 2 Study of 4-Aminopyridine for the Treatment of Episodic Ataxia Type 2[NCT01543750]Phase 20 participants (Actual)InterventionalWithdrawn
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for 4-aminopyridine and Ataxia of Gait

ArticleYear
4-aminopyridine and cerebellar gait: a retrospective case series.
    Journal of neurology, 2012, Volume: 259, Issue:11

    Topics: 4-Aminopyridine; Aged; Female; Gait Ataxia; Humans; Male; Middle Aged; Potassium Channel Blockers; R

2012

Other Studies

1 other study available for 4-aminopyridine and Ataxia of Gait

ArticleYear
Potassium channel blocker 4-aminopyridine is effective in interictal cerebellar symptoms in episodic ataxia type 2--a video case report.
    Movement disorders : official journal of the Movement Disorder Society, 2008, Jul-15, Volume: 23, Issue:9

    Topics: 4-Aminopyridine; Female; Gait; Gait Ataxia; Humans; Middle Aged; Potassium Channel Blockers; Treatme

2008